494 related articles for article (PubMed ID: 10955818)
21. Modulation of Hsf1 activity by novobiocin and geldanamycin.
Conde R; Belak ZR; Nair M; O'Carroll RF; Ovsenek N
Biochem Cell Biol; 2009 Dec; 87(6):845-51. PubMed ID: 19935870
[TBL] [Abstract][Full Text] [Related]
22. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
Schulte TW; Neckers LM
Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
[TBL] [Abstract][Full Text] [Related]
23. Synergistic inhibition of the glucocorticoid receptor by radicicol and benzoquinone ansamycins.
Rosenhagen MC; Young JC; Wochnik GM; Herr AS; Schmidt U; Hartl FU; Holsboer F; Rein T
Biol Chem; 2001 Mar; 382(3):499-504. PubMed ID: 11347901
[TBL] [Abstract][Full Text] [Related]
24. In the yeast heat shock response, Hsf1-directed induction of Hsp90 facilitates the activation of the Slt2 (Mpk1) mitogen-activated protein kinase required for cell integrity.
Truman AW; Millson SH; Nuttall JM; Mollapour M; Prodromou C; Piper PW
Eukaryot Cell; 2007 Apr; 6(4):744-52. PubMed ID: 17293484
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Hsp90 function delays and impairs recovery from heat shock.
Duncan RF
FEBS J; 2005 Oct; 272(20):5244-56. PubMed ID: 16218955
[TBL] [Abstract][Full Text] [Related]
26. Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitors.
Minami Y; Kiyoi H; Yamamoto Y; Yamamoto K; Ueda R; Saito H; Naoe T
Leukemia; 2002 Aug; 16(8):1535-40. PubMed ID: 12145695
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
28. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.
Yang J; Yang JM; Iannone M; Shih WJ; Lin Y; Hait WN
Cancer Res; 2001 May; 61(10):4010-6. PubMed ID: 11358819
[TBL] [Abstract][Full Text] [Related]
29. Geldanamycin restores a defective heat shock response in vivo.
Winklhofer KF; Reintjes A; Hoener MC; Voellmy R; Tatzelt J
J Biol Chem; 2001 Nov; 276(48):45160-7. PubMed ID: 11574536
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
[TBL] [Abstract][Full Text] [Related]
31. Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis.
Batulan Z; Taylor DM; Aarons RJ; Minotti S; Doroudchi MM; Nalbantoglu J; Durham HD
Neurobiol Dis; 2006 Nov; 24(2):213-25. PubMed ID: 16950627
[TBL] [Abstract][Full Text] [Related]
32. [Heat shock protein 90: novel target for cancer therapy].
Chen Y; Ding J
Ai Zheng; 2004 Aug; 23(8):968-74. PubMed ID: 15301726
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of heat shock transcription factor by GR.
Wadekar SA; Li D; Periyasamy S; Sánchez ER
Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
[TBL] [Abstract][Full Text] [Related]
34. Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives.
Maroney AC; Marugan JJ; Mezzasalma TM; Barnakov AN; Garrabrant TA; Weaner LE; Jones WJ; Barnakova LA; Koblish HK; Todd MJ; Masucci JA; Deckman IC; Galemmo RA; Johnson DL
Biochemistry; 2006 May; 45(17):5678-85. PubMed ID: 16634649
[TBL] [Abstract][Full Text] [Related]
35. Estrogen and regulation of heat shock protein expression in female cardiomyocytes: cross-talk with NF kappa B signaling.
Hamilton KL; Gupta S; Knowlton AA
J Mol Cell Cardiol; 2004 Apr; 36(4):577-84. PubMed ID: 15081317
[TBL] [Abstract][Full Text] [Related]
36. The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin.
Segnitz B; Gehring U
J Biol Chem; 1997 Jul; 272(30):18694-701. PubMed ID: 9228040
[TBL] [Abstract][Full Text] [Related]
37. Hsp90 inhibitor geldanamycin increases hsp70 mRNA stabilisation but fails to activate HSF1 in cells exposed to hydrostatic pressure.
Elo MA; Kaarniranta K; Helminen HJ; Lammi MJ
Biochim Biophys Acta; 2005 Mar; 1743(1-2):115-9. PubMed ID: 15777846
[TBL] [Abstract][Full Text] [Related]
38. The topoisomerase II-Hsp90 complex: a new chemotherapeutic target?
Barker CR; Hamlett J; Pennington SR; Burrows F; Lundgren K; Lough R; Watson AJ; Jenkins JR
Int J Cancer; 2006 Jun; 118(11):2685-93. PubMed ID: 16385570
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation.
Yun BG; Matts RL
Exp Cell Res; 2005 Jul; 307(1):212-23. PubMed ID: 15922741
[TBL] [Abstract][Full Text] [Related]
40. mTOR inhibition potentiates HSP90 inhibitor activity via cessation of HSP synthesis.
Acquaviva J; He S; Sang J; Smith DL; Sequeira M; Zhang C; Bates RC; Proia DA
Mol Cancer Res; 2014 May; 12(5):703-13. PubMed ID: 24554781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]